{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:56:50Z","timestamp":1791921410393,"version":"4.3.4"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:00:00Z","timestamp":1460678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153867","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T17:37:52Z","timestamp":1460741872000},"page":"e0153867","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Short-Fragment DNA Residue from Vaccine Purification Processes Promotes Immune Response to the New Inactivated EV71 Vaccine by Upregulating TLR9 mRNA"],"prefix":"10.1371","volume":"11","author":[{"given":"Jie","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Juan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun-Ying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Lun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature02761","article-title":"Inferences, questions and possibilities in Toll-like receptor signalling","volume":"430","author":"B Beutler","year":"2004","journal-title":"Nature"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"T Querec","year":"2006","journal-title":"J Exp Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.vaccine.2008.01.017","article-title":"Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results","volume":"26","author":"N Dhiman","year":"2008","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.vaccine.2010.11.023","article-title":"Toll-like receptors and cytokines\/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine","volume":"29","author":"J Chen","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0264-410X(97)00254-5","article-title":"Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system","volume":"16","author":"S Thoelen","year":"1998","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1016\/j.vaccine.2004.01.058","article-title":"Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine","volume":"22","author":"CL Cooper","year":"2004","journal-title":"Vaccine"},{"issue":"7335","key":"ref7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"SP Kasturi","year":"2011","journal-title":"Nature"},{"key":"ref8","first-page":"549","article-title":"The present status of rabies vaccine development and clinical experience with rabies vaccine","volume":"19","author":"M Roumiantzeff","year":"1988","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/infdis\/jit498","article-title":"Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population","volume":"209","author":"MV Velden","year":"2014","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.vaccine.2013.02.058","article-title":"A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial","volume":"31","author":"S Pichon","year":"2013","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.vaccine.2013.03.050","article-title":"Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers","volume":"31","author":"PS Kulkarni","year":"2013","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1016\/j.vaccine.2011.07.050","article-title":"Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination","volume":"29","author":"H Lagler","year":"2011","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.1016\/j.vaccine.2011.09.125","article-title":"Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial","volume":"29","author":"G Aichinger","year":"2011","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.vaccine.2011.10.088","article-title":"Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A\/Indonesia\/05\/2005) influenza vaccine","volume":"30","author":"PA Tambyah","year":"2012","journal-title":"Vaccine"},{"key":"ref15","first-page":"139","article-title":"Clinical evaluation of purified vero-cell rabies vaccine in patients bitten by rabid animals in India","volume":"26","author":"S Sehgal","year":"1994","journal-title":"J Commun Dis"},{"key":"ref16","first-page":"i","article-title":"WHO Expert Committee On Biological Standardization","volume":"878","year":"1998","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4161\/hv.22699","article-title":"Development of a Vero cell DNA reference standard for residual DNA measurement in China","volume":"9","author":"S Cao","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/0022-1317-59-1-197","article-title":"A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies","volume":"59","author":"M Ferguson","year":"1982","journal-title":"J Gen Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1021\/bm400426f","article-title":"A smart DNA tetrahedron that isothermally assembles or dissociates in response to the solution pH value changes","volume":"14","author":"Z Liu","year":"2013","journal-title":"Biomacromolecules"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biologicals.2014.06.005","article-title":"Removing residual DNA from Vero-cell culture-derived human rabies vaccine by using nuclease","volume":"42","author":"SM Li","year":"2014","journal-title":"Biologicals"},{"key":"ref21","first-page":"162","article-title":"Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22\u201323 April 2009, Bethesda, USA","volume":"38","author":"I Knezevic","year":"2010","journal-title":"Biologicals"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1389-1723(02)80212-2","article-title":"Process standardization for optimal virus recovery and removal of substrate DNA and bovine serum proteins in Vero cell-derived rabies vaccine","volume":"94","author":"AA Kumar","year":"2002","journal-title":"J Biosci Bioeng"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jctb.280490304","article-title":"Development of a chromatographic process for large-scale purification of staphylococcal enterotoxin B","volume":"49","author":"HJ Johansson","year":"1990","journal-title":"J Chem Technol Biotechnol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1038\/cti.2014.24","article-title":"EV71 vaccine, an invaluable gift for children","volume":"3","author":"Z Liang","year":"2014","journal-title":"Clin Transl Immunology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/pmic.201300073","article-title":"Study of rat hypothalamic proteome by HPLC\/ESI ion trap and HPLC\/ESI-Q-TOF MS","volume":"13","author":"J Iqbal","year":"2013","journal-title":"Proteomics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e111496","DOI":"10.1371\/journal.pone.0111496","article-title":"Enterovirus-71 virus-like particles induce the activation and maturation of human monocyte-derived dendritic cells through TLR4 signaling","volume":"9","author":"YL Lin","year":"2014","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1128\/JVI.00867-14","article-title":"Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns","volume":"88","author":"HB Hsiao","year":"2014","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e79599","DOI":"10.1371\/journal.pone.0079599","article-title":"The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children","volume":"8","author":"Q Mao","year":"2013","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"9668","DOI":"10.1016\/j.vaccine.2011.10.018","article-title":"Establishing China&apos;s national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines","volume":"29","author":"Z Liang","year":"2011","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00218-12","article-title":"Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2","volume":"3","author":"P Rallabhandi","year":"2012","journal-title":"MBio"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1073\/pnas.042355399","article-title":"Murine retroviruses activate B cells via interaction with toll-like receptor 4","volume":"99","author":"JC Rassa","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.4049\/jimmunol.1402755","article-title":"Minimal sequence requirements for oligodeoxyribonucleotides activating human TLR9","volume":"194","author":"J Pohar","year":"2015","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.imbio.2014.10.012","article-title":"TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections","volume":"220","author":"F Cannella","year":"2015","journal-title":"Immunobiology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"19780","DOI":"10.3402\/ehtj.v6i0.19780","article-title":"Human enterovirus 71 epidemics: what&apos;s next?","volume":"6","author":"CC Yip","year":"2013","journal-title":"Emerg Health Threats J"},{"key":"ref35","first-page":"136","article-title":"Safety of biological products prepared from mammalian cell culture. DNA","volume":"93","year":"1998","journal-title":"Dev Biol Stand"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4161\/hv.24949","article-title":"Progress on the research and development of inactivated EV71 whole-virus vaccines","volume":"9","author":"ZL Liang","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"Pt 3","key":"ref37","first-page":"209","article-title":"Use of nuclease enzyme in the purification of VAQTA, a hepatitis A vaccine","volume":"23","author":"AJ Hagen","year":"1996","journal-title":"Biotechnol Appl Biochem"},{"key":"ref38","unstructured":"European Medicines Agency (2009) Assessment Report for Celvapan. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000982\/WC500059446.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000982\/WC500059446.pdf<\/ext-link>. Accessed 2011 Nov 10. WHO Uppsala Monitoring Centre. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who-umc.org\/\" xlink:type=\"simple\">http:\/\/www.who-umc.org\/<\/ext-link>"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2144\/96206bm05","article-title":"Use of UV methods for measurement of protein and nucleic acid concentrations","volume":"20","author":"KL Manchester","year":"1996","journal-title":"Biotechniques"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/abio.1997.2177","article-title":"Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation","volume":"249","author":"VL Singer","year":"1997","journal-title":"Anal Biochem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/abio.1998.2914","article-title":"RNA quantitation by fluorescence-based solution assay: RiboGreen reagent characterization","volume":"265","author":"LJ Jones","year":"1998","journal-title":"Anal Biochem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T19:16:24Z","timestamp":1567797384000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153867"}},"subtitle":[],"editor":[{"given":"Shixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153867","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,15]]}}}